PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28189712-8	2017	The most striking result was the significant decrease in IL-1Ra after 8 weeks of anti-TB treatment (median reduction: -63% (p < 0.0001)).	Terbium	86-88	interleukin 1 receptor antagonist	Homo sapiens	57-63	
33317988-11	2021	CONCLUSIONS: IL-1RA level in the QFT-GIT supernatant can be a good marker for discriminating active TB from LTBI.	Terbium	100-102	interleukin 1 receptor antagonist	Homo sapiens	13-19	
33045524-8	2021	TB antigens induced the secretion of IL-1Ra in LTB+ subjects in the NGT, PDM and NDM groups, but not in the KDM group.	Terbium	0-2	interleukin 1 receptor antagonist	Homo sapiens	37-43	
28189712-11	2017	The substantial reduction of IL-1Ra under treatment suggests that IL-1Ra could be a surrogate biomarker of anti-TB treatment response in HIV-infected patients.	Terbium	112-114	interleukin 1 receptor antagonist	Homo sapiens	29-35	
28189712-11	2017	The substantial reduction of IL-1Ra under treatment suggests that IL-1Ra could be a surrogate biomarker of anti-TB treatment response in HIV-infected patients.	Terbium	112-114	interleukin 1 receptor antagonist	Homo sapiens	66-72